The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | B | Blood and blood forming organs | |
| 2 | B02 | Antihemorrhagics | |
| 3 | B02B | Vitamin K and other hemostatics | |
| 4 | B02BA | Vitamin K |
| Code | Title | |
|---|---|---|
| B02BA01 | Phytomenadione | |
| B02BA02 | Menadione |
| Active Ingredient | Description | |
|---|---|---|
| Vitamin K1 |
The presence of vitamin K (i.e. vitamin K or substances with vitamin K activity) is essential for the formation within the body of prothrombin, factor VII, factor IX and factor X. Lack of vitamin K leads to an increased tendency to haemorrhage. When an antidote to an anticoagulant is necessary it is essential to use vitamin K1 itself, as vitamin K analogues are much less effective. |
|
| Vitamin K2 |
|
|
| Menadione |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| KONAKION MM PAEDIATRIC Solution (ampoules) | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| KONAKION MM Solution (ampoules) | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
